- Home
- BROS vs HALO Comparison
BROS vs HALO Comparison
Compare BROS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BROS | HALO |
|---|---|---|
| Founded | 1992 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.4B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BROS | HALO |
|---|---|---|
| Price | $61.03 | $62.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 12 |
| Target Price | ★ $77.17 | $73.33 |
| AVG Volume (30 Days) | ★ 3.1M | 2.4M |
| Earning Date | 11-05-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 56.73 | 56.68 |
| EPS | 0.51 | ★ 4.74 |
| Revenue | ★ $1,537,335,000.00 | $1,242,852,000.00 |
| Revenue This Year | $28.73 | $34.83 |
| Revenue Next Year | $25.41 | $24.84 |
| P/E Ratio | $120.88 | ★ $13.14 |
| Revenue Growth | 28.93 | ★ 31.19 |
| 52 Week Low | $47.16 | $46.26 |
| 52 Week High | $86.88 | $79.50 |
Technical Indicators
Market Signals| Indicator | BROS | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 60.16 | 34.09 |
| Support Level | $57.30 | $61.23 |
| Resistance Level | $62.30 | $63.26 |
| Average True Range (ATR) | 2.25 | 2.42 |
| MACD | 0.38 | -0.79 |
| Stochastic Oscillator | 85.12 | 7.60 |
Price Performance
Historical ComparisonAbout BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.